Literature DB >> 15003825

A rare example that coinheritance of a severe form of beta-thalassemia and alpha-thalassemia interact in a "synergistic" manner to balance the phenotype of classic thalassemic syndromes.

Emmanuel Kanavakis1, Joanne Traeger-Synodinos, Stelios Lafioniatis, Christina Lazaropoulou, Theodora Liakopoulou, George Paleologos, Anna Metaxotou-Mavrommati, Alexandra Stamoulakatou, Ioannis Papassotiriou.   

Abstract

The coinheritance of beta-thalassemia major with the genotype of Hb H disease is extremely rare, with few reported cases. We investigated the hematological, biochemical, biosynthetic, molecular and pathophysiological parameters to evaluate a rare male patient with this compound syndrome. The patient was studied at first diagnosis during hospitalization at 50 years of age and subsequently followed up for more than a year. Examinations included full hematological, biochemical, biosynthetic, molecular, pathophysiological and clinical parameters. Besides standard parameters, we additionally measured reticulocyte hemoglobin content (CHr), erythropoietin (Epo), soluble transferrin receptors (sTfR), oxygen pressure at 50% hemoglobin saturation (P50), 2,3-bisphosphoglycerate (2,3-BPG), total glutathione (GSHt), oxidized glutathione (GSSG), malonyldialdehyde (MDA), nontransferrin-bound iron (NTBI), vitamins A and E. The male patient was first hospitalized for a 2-day period at 50 years of age, following the finding of marked anemia (hematocrit 20%) during a blood test to investigate the cause of fatigue in the absence of weight-loss or other notable symptomatology. He had never been transfused, maintaining Hb 85-95 g/l. Definitive diagnosis was achieved through DNA studies, which showed coexistence of beta-thalassemia major (IVSI-6 T > C/IVSI-I G > A) with Hb H disease (-alpha(3.7)/-(Med)). Alpha/non-alpha globin chain biosynthesis was completely balanced. Parameters demonstrated a well-compensated anemia with ineffective erythropoiesis and oxidative stress, which was ameliorated following splenectomy. In conclusion, this case is a remarkable example that the coinheritance of severe forms of beta-thalassemia and alpha-thalassemia interact in a "synergistic" manner to almost complete balance the symptoms of classic thalassemia syndromes.

Entities:  

Mesh:

Year:  2004        PMID: 15003825     DOI: 10.1016/j.bcmd.2003.12.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  4 in total

1.  Molecular characterization of β-thalassemia intermedia: a report from Iran.

Authors:  Aida Arab; Morteza Karimipoor; Ali Rajabi; Mohammad Hamid; Sedeigheh Arjmandi; Sirous Zeinali
Journal:  Mol Biol Rep       Date:  2010-12-01       Impact factor: 2.316

2.  Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.

Authors:  Catherine Badens; Philippe Joly; Imane Agouti; Isabelle Thuret; Katia Gonnet; Synda Fattoum; Alain Francina; Marie-Claude Simeoni; Anderson Loundou; Serge Pissard
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

3.  In Vitro Hb Production in B-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to Hydroxyurea.

Authors:  Mohammad Reza Mahdavi; Farzin Pourfarzad; Mehrnoush Kosaryan; Mohammad Taghi Akbari
Journal:  Iran J Public Health       Date:  2017-07       Impact factor: 1.429

4.  The phenomena of balanced effect between α-globin gene and of β-globin gene.

Authors:  Liangying Zhong; Xin Gan; Lingling Xu; Chujia Liang; Yingjun Xie; Wenbin Lin; Peisong Chen; Min Liu
Journal:  BMC Med Genet       Date:  2018-08-17       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.